Curriculum-Vitae-Ec-.Pdf

CURRICULUM VITAE

Name: Juergen Kurt Viktor REICHARDT

Birthdate: March 30th, 1958 in Rome/Italy

Citizenship: German; Ecuadorian and Australian Permanent Resident (formerly USA Permanent Resident)

Address: Prof. Juergen Reichardt

Vice Chancellor, Research and Innovation

YachayTech University San Miguel de Urcuquí, 100119 Ecuador +593 (0)62 999 130 ext. 2614 Email: [email protected]

Websites: Current: http://www.yachaytech.edu.ec/en/office/vice-chancellor-of-research-and- innovation/ http://www.linkedin.com/pub/juergen-reichardt/a/607/806 http://www.researchgate.net/profile/Juergen_Reichardt https://scholar.google.com.ec/citations?view_op=list_works&hl=en&user=N dnGSbsAAAAJ&cstart=0&pagesize=20

Older (but still active): http://sydney.edu.au/medicine/foundation/research/genome.php http://www.angelfire.com/ri2/reichardt/homereichardt.html

Education:

1976 German School Rome (Deutsche Schule Rom), Italy; High School Diploma (Abitur)

1976-1979 Universitaet Freiburg, Germany; Vordiplom; 1978: Biology; Universitaet Freiburg, Germany; Zwischenpruefung; 1979: Philosophy

1979-1981 Universitaet Basel, Switzerland; Diplom in Biologie II (Biochemistry); advisor: Prof. Gottfried (“Jeff”) Schatz

1982 Visiting Scientist: Section of Biochemistry, Molecular and Cell Biology, Cornell University, Ithaca, NY; mentor: Dr. Quentin H. Gibson

1982-1989 Graduate Education (PhD): Department of Biochemistry, Stanford University School of Medicine, Stanford, CA; advisor: Dr. Paul Berg

1989-1991 Postdoctoral Training: Baylor College of Medicine/Howard Hughes Medical Institute, Houston, TX; mentor: Dr. Savio L. C. Woo.

Academic Appointments:

1991-1992 Research Instructor: Department of Cell Biology, Baylor College of Medicine, Houston, TX, USA

1992-2000 Assistant Professor: Institute for Genetic Medicine and Department of Biochemistry and Molecular Biology, University of Southern California School of Medicine, Los Angeles, CA, USA

2000-2005 Associate Professor with tenure: Institute for Genetic Medicine and Department of Biochemistry and Molecular Biology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA

2000-2005 Associate Professor (dual appointment): Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA

2005-2011 Plunkett Chair and Professor of Molecular Biology (Medicine), University of Sydney, Camperdown NSW, Australia

2011-2014 Professor and Head, School of Pharmacy and Molecular Sciences, James Cook University, Townsville QLD, Australia

2012-2014 Associate Dean Research, Faculty Medicine, Health and Molecular Sciences, James Cook University, Townsville QLD, Australia

2015 Professor, Division of Tropical Health and Medicine, James Cook University, Townsville QLD, Australia

2016-present Vice Chancellor, Research and Innovation, YachayTech University, Ecuador

2016-2017 Acting Dean, Chemistry, YachayTech University, Ecuador.

Honors:

1979-1980 Fellowship: Deutscher Akademischer Austauschdienst (DAAD)

1992-1995 Basil O'Connor Starter Scholar Award (March of Dimes Young Investigator Award)

1993-1994 Fellow of the James H. Zumberge Faculty Research and Innovation Fund at the University of Southern California

1995-1996 New Investigator Award (USC Liver Disease Research Center)

2001-2005 Visiting Professor, Universidade Estadual de Campinas: Genetics and Molecular Biology, Campinas S.P., Brazil

2004 USC STAR Mentor of the Year

2005-2009 Medical Foundation Fellow; University of Sydney

2013 Visiting Professor, Tor Vergata University, Rome, Italy

2013-present HuGO (Human Genome Organisation International) Council

2014-present HuGO Senior Scholar

2016-present International Scientific Advisory Committee (ISAC), HVP (Human Variome Project)

2016-present Scientific Advisory Committee, the Golden Helix Foundation.

Professional Activities:

1991-2012 Member, American Society of Human Genetics (ASHG); USA

1992-2004 Member, Faculty Searches for the USC Institute for Genetic Medicine (IGM)

1992-1994 Co-Organizer, USC Eukaryotic Genetics Club

1993-1996 Member, USC Basic Science Seminar Committee

1993&1994 Co-Organizer, USC Biochemistry Retreat Committee

1993-1996 Member, USC/Norris Cancer Center Predoctoral Fellowship Committee

1994-1995 Chair, Basic Science Seminar Committee

1994-2005 Member, USC MD/PhD Committee

1995-2000 Associate Director, USC Center for Liver Diseases, Molecular Biology Core

1995-2005 Chair, USC IGM Distinguished Lectures in Genetic Medicine

1995-1998 Member, USC/Norris Scientific Review Committee

1995-1996 Member, Biochemistry Graduate Admissions Committee

1995-1996 Member, USC/Norris Urology Faculty Search

1995-2012 Member, American Association for Cancer Research (AACR); USA

1995-2005 Chair, USC IGM Library Committee

1995-1999 Member, USC HSC Patent Panel

1996-2004 Member, USC Medical School Graduate Council

1996-2005 Associate Director, USC MD/PhD Program

1996-1998 Chair, USC Health Sciences Junior Faculty Assembly

1996-1997 Member, USC Academic Senate Task Force on Health Sciences

1997 Chair, Awards Committee, Bravo Medical Magnet High School (LAUSD)

1997- 1999 Member, USC Psychiatry Chair Search

1997-1998 Member, USC School of Medicine Task Force on Tenure for Newly Recruited Faculty

1997-1998 Chair, USC Biochemistry/HHMI Neuroscience Faculty Search

1997-1998 Chair, 2nd Annual IGM/Markey Symposium (“GENomic GENetics”)

1998-2000 Member, USC School of Medicine Neurogenetic Initiative

1998-2000 Member, USC/Norris Cancer Center Predoctoral Fellowship Committee

1999-2005 Member, USC Medical Student Research Committee

2000-2001 Participant, USC-HSC Genomics Consortium

2000-2005 ad hoc-tenure committee for the USC Keck School of Medicine

2000-2005 Co-Director, Molecular Epi Graduate Program, USC Keck School of Medicine

2000-2004 Member, USC GCRC Molecular Medicine Core Director Search

2000-2001 Member, Provost’s Committee on Biochemistry Graduate Education

2000-2002 Organizer, “Med. School Biochem “TAing””, USC Keck School of Medicine

2001-2003 Presenter, USC Health Professions Open House

2001-2005 Member, USC/Norris Cancer Scholarship Awards Committee

2001-2004 (interim) Director, Molecular Medicine Core, GCRC, USC Keck School of Medicine

2002 Translator (D & I), National Standard, Cambridge, MA

2002-2003 Chair, IGM/Biochem “Genetics” faculty search, USC Keck School of Medicine

2002-2005 Member, CURE (Continuing Umbrella of Research Experience for minority students) Program, USC/Norris Cancer Center

2002 Scientific Advisory Board, Genteon, San Diego, CA

2002-2005 Co-Director, Edmondson Fellowship Program, USC Keck School of Medicine

2002-present Science Advisory Board, Arlington, VA

2003-2005 Member, Med. Student Research Forum, USC Keck School of Medicine

2004-2005 USC Ambassador

2005-2007 Member, Linee Guida Galattosemia committee; Regione Lazio, Italy

2005-2015 Member, Australian Society for Medical Research (ASMR); Australia

2005-2007 USyd Cancer and Cell Biology Research Network Steering Committee

2005-present International Advisory Committee: Pacific Rim Breast and Prostate Cancer Meeting series

2005-2006 International Organizing Committee: 3rd Pacific Rim Breast and Prostate Cancer Meeting; Fraser Island, Australia

2005-2006 Local Organizing Committee: 3rd Pacific Rim Breast and Prostate Cancer Meeting; Fraser Island, Australia

2006-2011 Member, USyd Cancer Research Network

2006 Chair, Pharmacogenomics session; International Congress of Human Genetics (ICHG 2006); Brisbane, Australia

2006 Chair, Ronald K. Ross Award Committee; 3rd Pacific Rim Breast and Prostate Cancer Meeting; Fraser Island, Australia

2006 Chair, Risk, Genetics (and Prevention) 1 Session; 3rd Pacific Rim Breast and Prostate Cancer Meeting; Fraser Island, Australia

2006 Chair, (Risk, Genetics and) Prevention 2 Session; 3rd Pacific Rim Breast and Prostate Cancer Meeting; Fraser Island, Australia

2006-2011 Member, Melanoma and Skin Cancer Research Institute (MASCRI); Australia

2006-2011 Member, Rebecca Cooper Prize committee; USyd

2006-2008 Co-Organizer, Sydney Cancer Symposium 2008 (SCC2008); USyd

2006-2008 Executive Committee, Australia and New Zealand Pharmacogenomics Interest Group

2006-2010 Chair, SIG Hormone Dependent Cancers; USyd

2007 Co-Organizer, Inaugural Bosch Institute Annual Scientific Meeting, “Genetics and Genomics”; USyd

2007-2009 Scientific Advisory Council, SUPAMAC (Sydney University/Prince Alfred Macromolecular Analysis Centre); Camperdown NSW

2007 Member, NHMRC Project Grant Review Panel (GRP) Genetics; Australia

2007-2010 Executive Council, Melanoma and Skin Cancer Research Institute (MASCRI); Australia

2007-2011 Member, Bosch Institute Prostate Cancer Focus Group; USyd

2008-present Member, Human Variome Project (HVP) Consortium

2008-present Member, HUGO International (Human Genome Organisation)

2008 International Organizing Committee: 4th Pacific Rim Breast and Prostate Cancer Meeting; Whistler, Canada

2008-2011 Steering Committee, Science Advisory Board

2008 Chair, Ron Ross Award, 4th Pacific Rim Breast and Prostate Cancer Meeting; Whistler, Canada

2008-2011 International Organizing Committee: 5th Pacific Rim Breast and Prostate Cancer Meeting; Australia

2009 Member, ARC (Australian Research Council) ERA (Excellence in Research) Journal Ranking

2009-2011 Local Organizing Committee: 5th Pacific Rim Breast and Prostate Cancer Meeting; Broome, Australia

2009-2010 Co-Organizer, Sydney Cancer Symposium 2010 (SCC2010); USyd

2009-2012 Co-Chair, Human Genome Meeting (HGM 2012; HUGO; Human Genome Organisation); Local Organising Committee; Sydney, Australia

2010-present Member, Australian-Canadian Prostate Cancer Research Alliance

2010 Member, CODCD (Centre for Obesity, Diabetes and Cardiovascular Diseases) Omics Design Group, USyd

2010-present Member, Human Variome Consortium

2010-2011 Chair, Ron Ross Award, 5th Pacific Rim Breast and Prostate Cancer Meeting; Kingscliff, NSW

2010-2011 Member, International Advisory Committee, 5th Pacific Rim Breast and Prostate Cancer Meeting; Kingscliff, NSW

2011 Selection Panel, Chemistry Lecturer, JCU (James Cook University) Cairns campus, Australia

2011-2014 Chair, School (Pharmacy and Molecular Sciences) Executive Meeting, JCU (James Cook University), Australia

2011-2014 Member, JCU (James Cook University) Cohort Doctoral Scheme Committee, Townsville

2011 Chair, JCU Biochemistry Lecturer Recruitment, Townsville, Australia

2011 JCU Nevitt Chemistry Chair Recruitment, Townsville, Australia

2011 JCU HR Deputy Director Recruitment, Townsville, Australia

2011-2014 JCU Vice Chancellor’s Advisory and Senior Staff Committee, Townsville, Australia

2011 JCU Research-Contingent-Employment Committee, Townsville, Australia

2011 Chemical Safety Focus, PWC, Brisbane, Australia

2011-2014 Occasional/Acting Faculty PVC representative: JCU Academic Board

2011-present JCU Senior Management Group (SMG), Townsville, Australia

2011-present Judge (HDR): North Queensland Festival of Life, Townsville, Australia

2011-2012 EIF Bid Management Team, JCU, Townsville, Australia

2012-2014 Steering Committee, Townsville Health Service District, Research Steering Committee

2012-2014 JCU LIEF Committee

2012-2014 JCU Faculty Research Committee

2012-2015 JCU Research Committee

2012 Chair, Faculty JCU Research Committee

2012 Chair, HGM 2012 Springer Poster Awards

2012-2014 Fire Warden: JCU Molecular Sciences Building

2012-2014 Lions/JCU MS Board

2012-2014 oral presentation judge, Townsville Hospital, annual Medical Research Symposium

2012-present member, Human Genome Organisation (HuGO)

2013 2013 AusBiotech National Conference - Supporting Queensland Working Group

2013-2015 Project Control Group (PCG): The Science Place, TSP (EIF- funded), JCU

2013-2014 chair, School (level 3) safety committee, JCU

2013-2014 Research Australia: JCU representative

2013-present Committee Member, Chen Distinguished Achievement Award in Human Genetics and Genomics, HuGO

2013-present Committee Member, Chen Investigator Award for Research Excellence, HuGO

2014 Chair, Faculty Research Committee, JCU

2014-2015 Management Committee, Australian Institute of Tropical Health and Medicine (AITHM)

2014 Participant, NHMRC CEO Roundtable on Genomics

2014-2015 Strategy Group - International Strategy, JCU Global Strategy & Engagement

2014-present Member, HuGO Council Nominating Committee

2014-present Member, HuGO Africa Award Committee

2015-2016 Member, AACR Publication Taxonomy Project

2015 International Advisory Group, 6th Pacific Rim Breast and Prostate Cancer Meeting; Stevenson, WA, USA

2015 Chair, Ron Ross Award, 6th Pacific Rim Breast and Prostate Cancer Meeting; Stevenson, WA, USA

2016-present Academic Council, YachayTech University, Ecuador

2016-present Infrastructure Committee, YachayTech University, Ecuador

2016-present Mathematics Faulty Search Committee, YachayTech University, Ecuador

2016-present Physics Faulty Search Committee, YachayTech University, Ecuador

2016 Editorial Committee, YachayTech University, Ecuador

2016-present Acting Dean, Chemistry, YachayTech University, Ecuador

2016-present International Advisory Committee (ISAC), HVP (Human Variome Project)

2016-present Scientific Advisory Council, Golden Helix Foundation

2016-present Biology Faulty Search Committee, YachayTech University, Ecuador

2016 Judge, Innovation Day, YachayTech University, Ecuador

2016-present Member, International Advisory Committee, 7th Pacific Rim Breast and Prostate Cancer Meeting; Australia

2017-present Member, Working Group: Proper reporting of sequence variants in journal articles, HVP

2017-present Geology Faulty Search Committee, YachayTech University, Ecuador

2017 Chair, HuGO-OECD Session, HGM 2017, Barcelona; Spain.

External Peer-Reviewer:

Editorial Boards

Cancer Epi. Biomark. Prev. (CEBP; Assoc. Editor: 2005- present) Frontiers Biosci. (1997-present) Frontiers Biosci. (Managing Editor: 2005) Frontiers in Genetics (section on Pharmacogenetics and Pharmacogenomics) (Review Editor: 2011-present) Future Oncology (2005-present) HuGO J. (Communicating Editor: 2014-2015) Human Genomics (Associate Editor: 2014-present) Int. J. Genet. Sci. (previously: J. Genet. Sci. and J. Genes Therap.) (2013-present) International Scholarly Research Notices (previously: ISRN Biochemistry) (2012-present) J. Clinical & Experimental Oncology (2016-present) J. Pharmaceut. Sci. & Emerg. Drugs (previously: Outlook on Emerging Drugs, editor: 2012-2015) (2012-present) The Prostate (2008-present)

Journals

Adv. Urol. Aging Health

Am. J. Hum. Genet. Am. J. Med. Genet. Ann. Epidemiol. Ann. Hum. Biol. Andrology Asian Journal of Andrology Biochem. Pharmacol. Biochim. Biophys. Acta Biol. Regul. Hom. Ag. Biomark. BioTechniques BMC Bioinformatics BMC Cancer BMC Genomics BMC Ped. Br. J. Cancer Cancer Cancer Biol. Ther. Cancer Detect. Prev. Cancer Epi. Biomark. Prev. Cancer Lett. Cancer Research Cell. Molec. Biol. Circ. Res. Clin. Cancer Research Clin. Chem. Clin. Endocrinol. Clin. Genetics Clin. Prostate Cancer Cytogen. Genome Res. Endocrinol. Endocrin. Rel. Cancer Epi. Rev. Eur. J. Hum. Genet. Eur. J. Pharmacol. Eur. Urol. Expert Opin. Med. Diag. Expert Opin. Pharmacother. Frontiers in Pharmacogenetics and Pharmacogenomics Frontiers in Microbiology Fut. Oncol. Gene Genetic Testing Genomics Hum. Genet. Hum. Genom. Hum. Molec. Gen. Hum. Mut. Int. J. Androl. Int. J. Cancer

Invest. New Drugs ISRN Biochemistry J. Androl. J. Biol. Reg. Hom. Ag. J. Cell. Physiol. J. Clin. Invest. J. Clin. Endocrin. Metabol. J. Comp. Effect. Res. J. Enz. Inh. Med. Chem. J. Urol. The Lancet Lett. Drug Des. Disc. Leukemia Molec. Biol. Rep. Molec. Cancer Molec. Cancer Ther. Molec. Genet. Metabol. Mutation Research Genomics Nat. Clin. Pract. Urol. Nature Genetics Nature Medicine Neurology Nucleic Acids Res. Pharmacogenomics Pharmacogenomics Journal PLoS ONE Prostate Cancer Prostate Journal Proceed. National Acad. Sci. USA Therapy Urol.

Grants

annual reviewer, Research Grants Council; Hong Kong, PR China (1999-2005; 2007-2010; 2013-present) frequent reviewer, Southern California Environmental Health Sciences Center, Los Angeles, CA ad hoc reviewer, Department of Veterans Affairs, Oncology Subcommittee; USA ad hoc reviewer, FIRB “Post Genomics”; Italy ad hoc reviewer, National Science Council, “Genomic Medicine”; Republic of China (Taiwan) ad hoc reviewer, NIH Medical Biochemistry study section; USA annual reviewer, Center for Environmental Epigenomics, USC (2001-2005) frequent reviewer, Telethon Italia; Italy ad hoc reviewer, NHMRC; Australia (various funding schemes) ad hoc reviewer, DoD; USA

ad hoc reviewer, National Research Council (CNR); Italy frequent reviewer, SCCF (Sydney Cancer Centre Fund); Australia reviewer, NHMRC Project Grant Review Panel (GRP) Genetics; Australia frequent reviewer, National Medical Research Council (NMRC); Singapore ad hoc reviewer, Prostate Cancer Foundation of Australia (PCFA); Australia triage reviewer, MRC Molecular and Cellular Medicine Board; UK ad hoc reviewer, Bosch Institute, Sydney University ad hoc reviewer, ARC (Australian Research Council) Future Fellowship frequent reviewer, ARC Early Career Researcher Scheme ad hoc reviewer, ANR (Agence Nationale de la Recherche, France) ad hoc reviewer, ARC Discovery ad hoc reviewer, NHMRC Early Career Fellowship ad hoc reviewer, CRC (Cooperative Research Centres) ad hoc reviewer, Netherlands Organisation for Scientific Research.

Academic Promotions

ad hoc reviewer: Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, MD ad hoc reviewer: Center for Cancer Research, National Cancer Institute, Bethesda, MD ad hoc reviewer: MD Anderson Cancer Center; Houston, TX ad hoc reviewer: University College Dublin, Ireland ad hoc reviewer: The University of Sydney ad hoc reviewer: University of Trento, Italy.

Institute Review

site visitor, Cancer Prevention Studies Branch and Basic Research Laboratory (NCI; Bethesda, MD) chair reviewer, Canada Excellence Research Chairs Program (CERC; Canada) international panel member 2012-14: ANVUR ((Italian) National Agency for the Evaluation of Universities and Research Institutes Scientific planning 2016-17: Instituto Nacional de Patrimonio Cultural (INPC; Ecuador).

Abstracts

Abstract Committee, American Society of Cancer Research (AACR) Annual Meeting 2003 AACR Cancer Prevention 2006 SCC2008, Abstract Committee, 2008 (Sydney Cancer Conference) SCC2012, Abstract Committee, 2010 HGM2012, Abstract Committee, 2011 (Human Genome Meeting) HGM2014, Abstract Committee, 2014 HGM2016, Abstract Committee, 2015.

Teaching Experience:

Didactic Teaching:

1982-1983 Teaching Assistant: Biochemistry 200; Stanford University School of Medicine, Stanford, CA

1990 & 1991 Participant: Summer Medical and Scientific Training (SMART), Baylor College of Medicine, Houston, TX

1991 Lecturer: Cell Biology 423 (Cellular and Molecular Biology of Disease), Baylor College of Medicine, Houston, TX

1993-1996 Lecturer: BIOC 561 (Eucaryotic Gene Expression), USC School of Medicine, Los Angeles, CA

1993 Participant: MAGIC Course (Molecular and Genetic Implications in Clinical Medicine), USC School of Medicine, Los Angeles, CA

1993-1998 Participant: USC/Bravo Project SEED (sponsored by the American Chemical Society; ACS)

1993-2005 Lecturer: 1st Year Human Biology (MD students); USC School of Medicine, Los Angeles, CA

1993-2005 Organizer, Coordinator and Principal Instructor: BIOC 602 (Current Topics in Human Molecular Genetics), USC School of Medicine, Los Angeles, CA

1995-2005 Lecturer: INTD 555 (Biochemical and Molecular Bases of Disease), USC School of Medicine, Los Angeles, CA

1998 Lecturer: PHBI 608 (Hypertension: Molecular Genetics of a Complex Physiologic Trait), USC School of Medicine, Los Angeles, CA

1998-2005 Lecturer: BIOC543 (Human Molecular Genetics), USC School of Medicine, Los Angeles, CA

1998-2005 Lecturer: Edmondson Summer Fellowship Program, USC School of Medicine, Los Angeles, CA

1998-2005 Participant and Lecturer: USC/HHMI/Bravo HS Program

1998 Lecturer: BISC403 (Advanced Molecular Biology), USC, Los Angeles, CA

2000-2002 Organizer: Med. School I Biochem “TAing”, USC, Los Angeles, CA

2000-2003 Coordinator: USC Biochemistry PhD Qualifying Exam for “Protein Structure and Enzyme Kinetics”

2001-2003 Lecturer: PHARM316 (Molecular Genetics and Therapeutics), USC School of Pharmacy, Los Angeles, CA (continued as PHRD505 (Molecular Genetics and Therapeutic) listed below)

2001-2005 Lecturer: PM533 (Genetic and Molecular Epidemiology), USC Keck School of Medicine, Los Angeles, CA

2001-2005 Course Coordinator: BIOC543 (Human Molecular Genetics), USC Keck School of Medicine, Los Angeles, CA

2001-2004 Lecturer: Methods in Clinical Investigations, USC Keck School of Medicine, Los Angeles, CA

2003-2005 Lecturer: PSCI599 (Pharmacogenomics), USC School of Pharmacy, Los Angeles, CA

2004-2005 Lecturer: PHRD505 (Molecular Genetics and Therapeutics), USC Keck School of Medicine, Los Angeles, CA

2004-2005 Coordinator: USC Biochemistry PhD Qualifying Exam for “Human Genetics”

2004-2005 USC Medical School Genetics Teaching committee

2005-2011 USyd, Lecturer ANAT3002 (Cells and Development)

2006-2011 USyd, Lecturer PUBH5019 (Cancer Control and Prevention)

2006-2011 USyd, Lecturer, MBG3 (Molecular Biology & Genetics)

2006 PhD Thesis Examiner: DL Marocco, University of Adelaide

2007 PhD Thesis Examiner: J Lai, Queensland University of Technology

2008-2011 Associate PhD Advisor: Mathew Kelly (PhD candidate, USyd)

2008-2012 Associate PhD Advisor: Gladys Ho (PhD candidate, USyd)

2009 PhD Thesis Examiner: FM Alvi, University of the Punjab, Pakistan

2010 Lecturer, MT0120: Medical Human Genetics, JCU (James Cook University), Townsville, QLD

2011 Lecturer, BC3101: Genes, Genomes and Development, JCU (James Cook University), Townsville, QLD

2011 MD Thesis Examiner, University of Otago, New Zealand

2016 faculty, Golden Helix Summer School: Cancer Genomics and Individualized Therapy, Syros, Greece.

Students Trained:

High School Students Trained: 1993-95: Pattie Tang (graduated from UCLA) Summer 1993: Sue-Jean Chang Summer 1994: Josh Banerjee (graduated from Harvard University) 1996-1998: Bernadette Hickman (graduated from Harvard University) Summer 1998: Katherine Tower 1998-1999: Mimi Chan Salomon Lara (Bravo HS; graduated from UCLA) Summer 1999: Asha Garretson (Maranatha HS) Nhuc Luong (Bravo HS; graduated from UCLA) Michael Pham (Rancho Cucamonga HS) 1999-2000: Nhuc Luong (Bravo HS; graduated from UCLA; currently enrolled in a PhD at UCI) 2000-2001: Sam Luong (Bravo HS; graduated from UCLA) Summer 2001: Vincent Chan (Pasadena Polytechnic) Meri Gukasyan (Bravo HS) Alice You (Pasadena Polytechnic) 2001-2002: Meri Gukasyan (Bravo HS; attended UCLA) Summer 2002: Anais Campa (Bravo HS; attended UCLA) Meri Gukasyan (Bravo HS; attended UCLA) Matt Kaptein (Providence HS) 2002-2003: Anais Campa (Bravo HS; attended UCLA) 2003-2004: Phung Luong (Bravo HS; attended UCI) Susan Luong (Bravo HS; attended UCI).

College Summer Students Trained: Summer 1993: Bob Peters (U. Wisconsin) Summer 1994: Anne Tanabe (U. Chicago) Summer 1995: Gloria Wang (MIT) Summer 1997: Cecilia Wu (USC)

Summer 1998: Huong Tran (UC Berkley) Summer 1999: Sandra So Hee Chi (Stanford U.) Summer 2000: Frank Luh (Cornell U.) Summer 2001: Aisha Shaheen (USC) Summer 2002: Albert Kim (USC) Summer 2003: Jennifer I. Lo (UC Berkley) Chirag Patel (USC) Summer 2004: Phung Luong (UC Irvine) Susan Luong (UC Irvine) Aline Penverne (Strasbourg; France) Summer 2005: Hui-Hui “Kitty” Zhou (MIT) Summer 2007-08: Febriani “Febri” Changi (UTS) Summer 2008-09: Hovik Karghaian (UTS) Summer 2009-2010: Homaira Wahib (UTS).

Undergraduate Students Trained 1998-1999: Jonathan Koo (USC) Frank Tsai (USC) 1999: Deepti Hemrajani (USC) Patricia Sharpe (USC) 1999-2001: Claudia Weihe (Universitaet Greifswald; Germany) 2001-2002: Ann Ekmark (Uppsala University; Sweden) Rahul Shah (USC) 2002-2003: Albert Kim (USC) 2003: Neil Rampal (USC) 2006: Maren Stindt (USyd) 2007: Ibrahim Al-Odat (USyd) 2008: Raffaele Ottaviano (Naples; Italy).

Honours Students Trained 2006: Jonathan Chan (USyd) Florence Cheung (USyd).

MS Students Trained: 1993-1995: Hsien-Chin Lin (USC) 1993-1995: Sriveda Koritala (USC) 1994-1996: Sunita Devgan (USC) 1997-1999: Jeffrey Jim (USC; graduated from med. school at UCI) 1999-2000: Lana Ali (USC) Justin Fuess (USC) Jonathan Koo (USC; graduated med. school in Canada) 1999-2002: Soorena Izadifar (USC) 2000-2002: Eugene Kim (USC) Patricia Sharpe (USC) Ya-hsuan “Nancy” Hsu (USC) Shih-chi “Nancy” Chen (USC; attended Dental School at Penn) 2001: Duk-Won “Duck” Kang (USC) 2001-2003: Prutha Badiani (USC)

2002: Tom Reese (USC) Althea McCourty (USC) 2002-2004: Frank Luh (USC) 2003-2005: Xuemei “Mei” Deng (USC) Albert Kim (USC; graduated med. school in Virginia) Chirag Patel (USC) 2006-2008: Francine Marques (Brazil) 2009: Adena Spiro (USyd) Nguyen Viet Trung (USyd) 2009-2010: Dominique Petit (USyd).

PhD Students Trained: 1993-1995: Nathalie Daude (PhD obtained in Bordeaux, France) 1994-1997: Nick Makridakis (USC PhD) 1999-2003: Lucio Ferraz (PhD obtained in Brazil) 2001-2006: Troy Phipps (USC PhD; DoD Fellowship Recipient) 2002-2004: Eugene Kim (USC) 2007-2012: Florence Cheung (USyd).

Postdoctoral MD Fellows Trained: 1993-1994: Teodor Podskarbi (returned to Germany) 1995-1996: Donald Elmajian (currently on faculty at LSU Shreveport; after a first stint at UOK) 1996-1998: Ralph Highshaw 2000-2003: Tesfaye “Tes” Dessissa (returned to Germany).

Postdoctoral PhD Fellows Trained: 1995-1997: Patrizia Maceratesi (returned to Italy) 1996: Sergi Castellvi-Bel (returned to Spain) 1997-2001: Nick Makridakis (currently on faculty at 1Globe) 1997-2001: Abebe Akalu (currently in New York City) 1999-2002: Katia Margiotti (currently in Italy) 1999-2004: Dolly Foti 2002-2004: Ying “Lucy” Lu 2003-2005: Clemente Capasso (currently in Italy) 2006-2008: Lucia Musumeci (currently in Belgium) 2007-2010: Sarah Curtis (returned to the UK) 2010: Linda Colecchi (Go8 Award; L’ Aquila University; Italy).

Funding History:

March of Dimes Basil O’ Connor (Young Investigator) Award Genetic and Biochemical Basis of Galactosemia J. Reichardt, PI 1992-1995

Zumberge Faculty Research and Innovation Fund Award A Combined Biochemical and Genetic Analysis of Human Galactose-1-phosphate Uridyl Transferase J. Reichardt, PI

1993-1995

ACS-IRG (American Cancer Society) Ovarian Cancer and the Human Galactose-1-phosphate Uridyl Transferase (GALT) Gene J. Reichardt, PI 1994-1995

Wright Foundation Ovarian Cancer and the Human Galactose-1-phosphate Uridyl Transferase (GALT) Gene J. Reichardt, PI 1994-1996

NIDDK P30 DK48522 New Investigator Award J. Reichradt, PI 1995-1996

NIDDK P30 DK48522 Molecular Basis of Epimerase Deficiency Galactosemia (P/F Project) N. Kaplowitz, PI,; J. Reichardt, PI of P/F project 1995-1997

NCI P30 CA14089-22 Translational Research Project Benign Prostatic Hyperplasia and the Human SRD5A2 Gene P. Jones, PI; J. Reichardt, PI of project 1997-1998

NCI R01 CA61132 Case/Control Study of Ovarian Cancer in Los Angeles M. Pike, PI; J. Reichardt, Co-PI 1994-1998

NCI R01 CA68581 5-Alpha Reductase Genotype, Race and Prostate Cancer Risk J. Reichardt, PI 1995-2004

NIDDK P30 DK48522 USC Liver Disease Research Center N. Kaplowitz, PI; J. Reichardt, Associate Director, Molecular Biology Core 1995-2000

ACS 4-21-98 (American Cancer Society) Molecular Epidemiology of Prostate Cancer and Hyperplasia

J. Reichardt, PI (for Nick Makridakis, PhD; postdoctoral fellow) 1998-2000

NCI U01 CA63464 Genetic Susceptibility to Cancer in Multiethnic Cohorts B. Henderson, PI; J. Reichardt, Co-PI 1996-2006

NCI R03 CA83112 Variation of the HSD17B3 Gene and Prostate Cancer J. Reichardt, PI 1999-2001

Martell Foundation Androgen-Metabolic Genes and Prostate Cancer Risk: A Molecular Epidemiologic Investigation of the HSD3B2 Gene J. Reichardt, PI 1998-2002

CRP 864A-8704-S3516 Mutations, Oral Contraceptives and Ovarian Cancer W. Cozen, PI; J. Reichardt, Co-PI 1999-2001

CRP 99-0053V-10150 Benign Prostatic Hypertrophy (BPH) and the SRD5A2 Gene J. Reichardt, PI 1999-2001

SWOG COOP-02014 Androgen and 5-Alpha Reductase Pilot for the PCPT J. Reichardt, PI 2002-2003

NCI R01 CA84979 Risk Factors for Advanced Prostate Cancer S. Ingles, PI; J. Reichardt, Co-PI 1999-2004

DoD Prostate Cancer Center PC992018 Molecular Determinants of Prostate Cancer Risk and Progression Across Racial-Ethnic Groups R. Ross, PI; J. Reichardt, Co-PI; PI (JR) of Project 1 2000-2003

Wright Foundation Molecular Epidemiology of the Human 3-Hydroxy 3 methylglutaryl Coenzyme A Reductase (HMGCR) Gene and Atherosclerosis

J. Reichardt, PI 2003-2004

Fondazione Berti per l’ Arte e la Scienza Supplementation for Dr. Clemente Capasso J. Reichardt, PI 2004-2005

DoD PC 001280 Genetic Variation of the HSD3B2 Gene and Prostate Cancer J. Reichardt, PI 2001-2004

GSK Steroid 5 Alpha Reductase Inhibitors: Biochemical, Genetic and Molecular Investigations J. Reichardt, PI 2003-2004

DoD PC020368 SRD5A1 Genetic Variation and Prostate Cancer Epidemiology Predoctoral Fellowship for Troy Phipps J. Reichardt, nominal PI 2003-2006

CRP 3GS0106 SRD5A1 Genetic Variation and Prostate Cancer Epidemiology Predoctoral Fellowship for Troy Phipps J. Reichardt, nominal PI 2003-2006 (declined due to overlap with the DoD fellowship above)

NCI R01 CA96830 Molecular Epidemiology of Colorectal Adenomas R. Haile, PI; J. Reichardt, Co-PI 2003-2006

NHLBI R01 HL079353 Role of the 5-Lipoxygenase Pathway in Atherosclerosis H. Allayee, PI; J. Reichardt, Co-PI (Co-PI declined because of move to Australia) 2005-2009

ARC LE0775587 Correlating Genomics and Proteomics for Systems Biology: integrating the '-omics' Bergquist, Baker, Ferrari, Dawes, Graham, Stock, Trent, Hunt, Reichardt, Scott 2007

Cancer Institute NSW 07/RIG/01-36 PHERAstar and POLARstar Optima Multi-functional Plate Readers with Robotic High Throughput Screening System for Multi-Disciplinary Cancer Research Richardson (CI1), Reichardt (CI5) et al. 2007

ARC DP0771015 Discovering Genes for Complex Traits Involving Gene-Environment Interactions Yu, Trent, Pamphlett, Reichardt 2007

ARC LE0882512 Advanced High Throughput Functional Genomics and Gene Mapping Dawes, Bergquist, Trent, Scott, Hogg, Wilkins, Reichardt, Hunt, Baker, Dunkley 2008

NHMRC equipment grant A Large-Scale Recombinant Protein Production System for the New Multi-User PC2 Molecular Biology Facility in the Blackburn-Bosch Precinct DR Richardson, Stocker R. Halliday, G.M., Hunt N.H., Vandenberg R, Twigg S, Black J.L., Bishop G.A., King, N.J.C., Allen D.G., Mason R.S., Sharland, A.F., Lee C.S., Grau G. E., Chan-Ling T, Ju Y.K., Lovicu F. J., Joshua D.E., McLennan S.V., Dampney R.A.L, Bao S., Zreiqat H., Chadban S.J., Ho P.J., Burgess J.K., Wu H., Ryan R.M., Lovejoy D.B., Hambly B.D., Codd R., Reichardt JK. 2008

Medical Foundation J. Reichardt, CI 2005-2009

NHMRC 402516 Pharmacogenetics of Androgen Action: Activating Metabolism and Tissue Sensitivity D. Handelsman (CI A); J. Reichardt (CI B) 2006-2009

NCI P01 CA108964 Biology of the Prostate Cancer Prevention Trial (PCPT) S. Lippman, PI (up to 2009; then I. Thompson); J. Reichardt PI of project 1 2005-2010 (no cost extension to 2014)

ARC LE100100130

Next Generation Sequencing Bergquist, Baker, Ferrari, Dawes, Graham, Stock, Trent, Hunt, Reichardt, Scott 2010

Cancer Institute NSW 07/RIG/01-36 PHERAstar and POLARstar Optima multi-functional plate readers with robotic high throughput screening system for multi- disciplinary cancer research DR Richardson, Halliday GM, Lee CS, Joshua D, Reichardt J, Ho PJ, Dong Q, Iland HJ, Mason R, Grau GE, Assinder S, King NJC, Hunt N, Lovejoy D, Murphy C, Bishop GA, Sharland AF, Conigrave A, Cook D. 2007-2011

Cancer Institute NSW 09/REG/1-07 PALM Microbeam Laser Microdissection (LM) Microscope for the Multi-User Sydney Cancer Gene Expression Facility Prof. Des Richardson, Prof. Gary Halliday, Prof. Rebecca Mason, Prof. Chris Murphy, A/Prof. Naresh Kumar, Dr Lisa Horvath, Prof. Wolfgang Weninger, Prof Cheok Soon Lee, Dr Guy Lyons, Prof. Peter Lay, Dr Michael Boyer, Dr Scott Byrne, Dr Stephen Assinder, Dr Yohan Rahmanto, A/Prof Harry Iland, A/Prof Joanne Jamie, A/Prof Subramanyan Vemulpad, Prof. Mathew Vadas, Dr Jenny Gamble, A/Prof Shisan Bao, Prof. Trevor Hambley, Dr Nikolas Haass, Prof. Mathew Vadas, Dr Phillipa O'Brien, Prof. James Kench, A/Prof. Qihan Dong, Dr Danuta Kalinowski, Prof. Jeurgen Reichardt, Prof. John Rasko, Dr David Lovejoy, Prof Nick King 2009-2014

PCFA 2009 Luminex 200 Analysis System for the Bosch Prostate Cancer Research Focus Group in the Multi-User Bosch Institute Molecular Biology Facility Richardson DR, Reichardt JKV, Dong Q, Lee CS, Assinder SJ, Kalinowski D, Lovejoy D, Mangs H, Dixon K, Murphy CR 2009-2012

Cancer Institute of NSW Research Equipment Grant 10/REG/1-16 GenomeLab GeXP Genetic Analysis System for the Multi- Disciplinary Sydney Cancer Gene Expression Facility Richardson DR, Halliday GM, Scolyer R, Clarke S, Lee CS, Reichardt JK, Murray M, Clarke C, Boyer M, Kefford R, Mason RS, Murphy CR, McLachlan, Gamble JR, Lay P, Dong Q, Kumar N, Lyons G, Byrne G, Gurney HP, Davies M, Assinder SJ, Rahmanto Y, Jamie J, Vemulpad S, Bao S, Haass NK, Kench , JG, Kalinowski DS, Lovejoy DB, Groundwater P, Hawkins C, De Souza P, Lane D, Zhang D, Moscato P, Lai D

2010-2011

PCFA 2011 xCELLigence Real Time Cell Analysis System Richardson D, Reichardt J, Dong Q, Lee C, Assinder S, Kalinowski D, Lovejoy D, Dixon, K, Mangs H, Murphy C 2011-2014

Heart Foundation (Australia) G 10S 5276 Molecular Characterization of Genetic Variants in HMG CoA Reductase (HMGCR) and Their Association with Response to Statins Reichardt, J (PI), Keech, A, Tonkin, A, Yu, B 2011-2013 (declined due to heavy administrative load)

EIF (Education Investment Fund; Department of Industry, Innovation, Climate Change, Science, Research and Tertiary Education; Australia) The Science Place (TSP); JCU 2013-2016.

Consulting

1998 Nanogen; San Diego, CA 1999 Uro-Genesys; Santa Monica, CA 1999 Plaza Research; San Francisco, CA 2000 Myriad Genetics; Salt Lake City, UT 2001 Meczka Marketing/Research/Consulting; Los Angeles, CA 2002 Sudler & Hennessey; New York, NY 2002 Genteon; San Diego, CA 2002-2010 Glaxo Smith Kline (Avodart Think Tank); Research Triangle Park, NC 2004-2010 Vista Research Society of Industry Leaders; New York, NY 2007-2010 SUPAMAC (Sydney University Prince Alfred Macromolecular Analysis Centre) Scientific Advisory Board; Sydney, NSW 2008-2010 Science Advisory Board Steering Committee 2012-2015 Advisory Board: Centre for Biodiscovery and Molecular Development of Therapeutics (BMDT), JCU.

Patents

Patent Awarded: “Androgen-Metabolic Gene Mutations and Prostate Cancer Risk”; US Patent 09/235,538; 2/2002.

LIST OF PUBLICATIONS

Peer-Reviewed Articles

1. Reichardt, J.K.V. and Q.H. Gibson (1982) Spectra of Intermediates in Oxidation and Reduction of Cytochrome c Oxidase, J. Biol. Chem. 257, 9268- 9270

2. Reichardt, J.K.V. and Q.H. Gibson (1983) Turnover of Cytochrome c Oxidase from Paracoccus denitrificans, J. Biol. Chem. 258, 1504-1507

3. Reichardt, J.K.V. and P. Berg (1988) Cloning and Characterization of a cDNA Encoding Human Galactose-1-phosphate Uridyl Transferase, Molec. Biol. Med. 5, 107-122

4. Reichardt, J.K.V. and P. Berg (1988) Conservation of Short Patches of Amino Acid Sequence Amongst Proteins with a Common Function but Evolutionarily Distinct Origins: Implications for Cloning Genes and for Structure-Function Analysis, Nucl. Acids Res. 16, 9017-9026

5. Flach, J.E., J.K.V. Reichardt and L.J. Elsas (1990) Sequence of a cDNA Encoding Human Galactose-1-Phosphate Uridyl Transferase, Mol. Biol. Med. 7, 365-369

6. Reichardt, J.K.V. and S.L.C. Woo (1991) Molecular Basis of Galactosemia: Mutations and Polymoprhisms in the Gene Encoding Human Galactose-1- Phosphate Uridylyltransferase, Proc. Natl. Acad. Sci. 88, 2633-2637

7. Petry, K., H.T. Greinix, E. Nudelman, H. Eisen, S. Hakomori, H.L. Levy and J.K.V. Reichardt (1991) Characterization of a Novel Biochemical Defect in Galactosemia: Deficiency of Glycolipids Containing Galactose or N- Acetylgalactosamine and Accumulation of Precursors, Biochem. Med. Metabol. Biol. 46, 93-104

8. Reichardt, J.K.V., S. Packman and S.L.C. Woo (1991) Molecular Characterization of Two Galactosemia Mutations: Correlation of Mutations with Highly Conserved Domains in Galactose-1-Phosphate Uridyl Transferase, Am. J. Hum. Genet. 49, 860-867

9. Reichardt, J.K.V. (1991) Molecular Analysis of 11 Galactosemia Patients, Nucl. Acids Res. 19, 7049-7052

10. Reichardt, J.K.V., J.W. Belmont, H.L. Levy and S.L.C. Woo (1992) Characterization of Two Missense Mutations In Human Galactose-1- Phosphate Uridyl Transferase: Different Molecular Mechanisms for Galactosemia, Genomics 12, 596-600

11. Reichardt, J.K.V., H.L. Levy and S.L.C. Woo (1992) Molecular Characterization of Two Galactosemia Mutations and One Polymorphism:

Implications for Structure-Function Analysis of Human Galactose-1- phosphate Uridyl Transferase, Biochem. 31, 5430-5433

12. Reichardt, J.K.V. (1992) Genetic Basis of Galactosemia, Human Mut. 1, 190- 196

13. Reichardt, J.K.V. (1993) The Molecular Genetic Basis of Galactosemia, Int. Ped. 8, 110-113

14. Reichardt, J.K.V., G. Novelli and B. Dallapiccola (1993) Molecular Characterization of the H319Q Galactosemia Mutation, Hum. Molec. Genet. 2, 325-326

15. Lin, H.-C., L.T. Kirby, W.G. Ng and J.K.V. Reichardt (1994) On the Molecular Nature of the Duarte Variant of Galactose-1-phosphate Uridyl Transferase (GALT), Hum. Genet. 93, 167-169

16. Podskarbi, T., J. Reichardt and Y.S. Shin (1994) Studies of DNA in Galactose-1 phosphate Uridyl Transferase Deficiency and the Duarte Variant in Germany, J. Inher. Metabol. Dis. 17, 149-150

17. Kaufman, F.R., Reichardt, J.K.V., Ng, W.G., Xu, Y.-K., Manis, F.R., McBride Chang, C. and Wolff, J.A. (1994) Correlation of Cognitive, Neurologic and Ovarian Outcome with the Q188R Mutation of the Galactose- 1-phosphate Uridyltransferase Gene, J. Ped. 125, 225-227

18. Ng, W.G., Xu, Y.-K., Kaufman, F.R., Donnell, G.N., Wolff, J., Allen, R.J., Koritala, S. and Reichardt, J.K.V. (1994) Biochemical and Molecular Studies of 132 Patients with Galactosemia, Hum. Genet. 94, 359-363

19. Cramer, D.W., Muto, M.G., Reichardt, J.K.V., Xu, H., Welch, W.R., Valles, B. and Ng, W.G. (1994) Characteristics of Women With a Family History of Ovarian Cancer: I. Galactose Consumption and Metabolism, Cancer: 74, 1309-1317

20. Cramer, D.W., Barbieri, R.L., Xu, H. and Reichardt, J.K.V. (1994) Determinants of Basal Follicle Stimulating Hormone Levels in Premenopausal Women, J. Clin. Endo. Metabol. 79, 1105-1109

21. Lin, H.-C. and Reichardt, J.K.V. (1995) Linkage Disequilibrium Between a Sac I Restriction Fragment Length Polymorphism and two Galactosemia Mutations, Hum. Genet. 95, 353-355

22. Reichardt, JKV (1995) Mutations in Galactosemia, Am. J. Hum. Genet. 57, 978-979

23. Ashino, J., Okano, Y., Suyama, I., Yamazaki, T., Yoshino, M., Furuyama, J.- I., Lin, H.-C., Reichardt, J.K.V. and Isshiki, G. (1995) Molecular Characterization of Galactosemia Mutations (Type 1) in Japanese, Hum. Mut. 6, 36-43

24. Ross, R.K., Coetzee, G., Reichardt, J., Skinner, E. and Henderson, B.E. (1995) Does the Racial-Ethnic Variation in Prostate Cancer Have a Hormonal Basis?, Cancer 75, 1778-1782

25. Daude, N., Gallaher, T.K., Zeschnigk, M., Starzinski-Powitz, A., Petry, K.G., Haworth, I.S. and Reichardt, J.K.V. (1995) Molecular Cloning, Characterization and Mapping of A Full-Length cDNA Encoding Human UDP-Galactose 4' Epimerase, Biochem. Molec. Med. 56, 1-7

26. Reichardt, J.K.V., Makridakis, N., Henderson, B.E., Yu. M.C., Pike, M.C. and Ross, R.K. (1995) Genetic Variability of the Human SRD5A2 Gene: Implications for Prostate Cancer Risk, Cancer Res. 55, 3973-3975

27. Maceratesi, P., Sangiulo, F., Novelli, G., Ninfali, P., Magnani, M., Reichardt, J.K.V. and Dallapiccola, B. (1996) Three New Mutations (P183T, V150L, 528insG) and Eleven Sequence Polymorphisms in Italian Patients with Galactose-1-phosphate Uridyltransferase (GALT) Deficiency, Hum. Mut. 8, 369-372

28. Gathof, B.S., Sommer, M., Podskarbi, T., Reichardt, J.K.V., Braun, A., Gresser, U. and Shin, Y.S. (1995) Characterization of Two Stop Codon Mutations in the Galactose-1-phosphate Uridyltransferase Gene of Three Male Galactosemic Patients with Severe Clinical Manifestation, Hum. Genet. 96, 721-725

29. Daude, N., Lestage, J., Reichardt, J.K.V. and Petry, K.G. (1996) Expression of Galactose-1-phosphate Uridyltransferase (GALT) in the Anterior Pituitary of Rat During the Estrous Cycle, Neuroendocrin. 64, 42-48

30. Cramer, D.W., Goldstein, D.P., Fraer, C. and Reichardt, J.K.V. (1996) Vaginal Agenesis (Mayer-Rokitansky-Kuster-Hauser Syndrome) Associated with the N314D Mutation of Galactose-1-phosphate Uridyl Tranferase (GALT), Molec. Hum. Reprod. 2, 145-148

31. Daude, N., Ellie, E., Reichardt, J.K.V. and Petry, K.G. (1996) In Vivo and InVitro Expression of Rat Galactose-1-phosphate Uridyltransferase (GALT) in Developing Central and Peripheral Nervous System, Develop. Brain Res. 94, 190-196

32. Feigelson, H.S., Ross, R.K., Yu, M.C., Coetzee, G.A., Reichardt, J.K.V. and Henderson, B.E. (1996) Genetic Susceptibility to Cancer from Exogenous and Endogenous Exposures, J. Cell. Biochem. 25, 15-22

33. Devgan, S.A., Henderson, B.E., Yu, M.C., Shi, C.-Y., Pike, M.C., Ross, R.K. and Reichardt, J.K.V. (1997) Genetic Variation of 3-Hydroxysteroid Dehydrogenase Type II in Three Racial/Ethnic Groups: Implications for Prostate Cancer Risk, The Prostate 33, 9-12

34. Makridakis, N., Ross, R.K., Pike, M.C., Chang, L., Stanczyk, F.Z., Kolonel, L.N., Shi, C.-Y., Yu, M.C., Henderson, B.E. and Reichardt, J.K.V (1997) A Prevalent Missense Substitution that Modulates Activity of Prostatic Steroid 5-Reductase, Cancer Res. 57, 1020-1022

35. Feigelson, H.S., Ross, R.K., Yu, M.C., Coetzee, G.A., Reichardt, J.K.V. and Henderson, B.E.H. (1998) Sex Steroid Hormones and Genetic Susceptibility to Breast and Prostate Cancer, Drug Metab. Rev. 30, 421-434

36. Maceratesi, P., Daude, N., Dallapiccola, B., Novelli, G., Allen, R., Okano, Y. and Reichardt, J. (1998) Human UDP-Galactose 4’ Epimerase (GALE) Gene and Identification of Five Missense Mutations in Patients with Epimerase Deficiency Galactosemia, Molec. Genet. Metabol. 63, 26-30

37. Petry, K.G. and Reichardt, J.K.V. (1998) The Fundamental Importance of Human Galactose Metabolism: Lessons from Genetics and Biochemistry, Trends Genet. 14, 98-102

38. Ross, R.K., M.C. Pike, G.A. Coetzee, J.K.V. Reichardt, M.C. Yu, H. Feigelson, F.Z. Stanczyk, L.N. Kolonel and B.E. Henderson (1998) Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility, Cancer Res. 58, 4497-4504

39. Akalu, A., Elmajian, D.A., Highshaw, R.A., Nichols, P.W. and Reichardt, J.K.V. (1999) Somatic Mutations at the SRD5A2 Locus Encoding Prostatic Steroid 5-Reductase During Prostate Cancer Progression, J. Urol. 161, 1355- 1358

40. Ross RK, Coetzee GA, Pearce CL, Reichardt JK, Bretsky P, Kolonel LN, Henderson BE, Lander E, Altshuler D, Daley G (1999) Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility, Eur. Urol. 35, 355-361

41. Reichardt JK (1999) GEN GEN: the Genomic Genetic Analysis of Androgen Metabolic Genes and Prostate Cancer as a Paradigm for the Dissection of Complex Phenotypes, Frontiers in Bioscience 4, D596-600

42. Tyfield, L., Reichardt, J., Fridovich-Keil, J. et al. (1999) Classical Galactosaemia and Mutations at the Galactose-1-phosphate Uridyl Transferase (GALT) Gene, Hum. Mut. 13, 417-430

43. Makridakis, N.M, Ross, R.K, Pike, M.C., Crocitto, L.E., Kolonel, L.N., Pearce, C.L., Henderson, B.E. and Reichardt, J.K.V. (1999) A Missense Substitution in the SRD5A2 Gene is Associated with Prostate Cancer in African-American and Hispanic Men in Los Angeles, The Lancet 354, 975- 978

44. Reichardt, J.K.V. (2000) Prostatic Steroid-5-Alpha Reductase, an Androgen Metabolic Gene, Mayo Clin. Proc. 75, S36-39

45. Akalu, A. and Reichardt, J.K.V. (1999) A Reliable PCR Amplification Method for Microdissected Tumor Cells Obtained from Paraffin-Embedded Tissue, Gen. An. 15, 229-233

46. Makridakis, N.M., di Salle, E. and Reichardt, J.K.V. (2000) Biochemical and Pharmacogenetic Dissection of Human Steroid 5-Reductase Type II, Pharmacogenet. 10, 407-413

47. Novelli, G and Reichardt, J.K.V. (2000) Molecular Basis of Disorders of Galactose Metabolism: Past, Present and Future, Molec. Genet. Metabol. 71, 62-65

48. Margiotti, K, Sangiulo, F, de Luca, A, Froio, F, Pearce, CL, Ricci-Barbine, V, Micali, F, Bonafe, M, Dallapicccola, B, Novelli, G and Reichardt, JKV (2000) Evidence for an Association between the SRD5A2 (Type II Steroid 5-Reductase) Locus and Prostate Cancer in Italian Patients. Dis. Markers 16, 147-150

49. Novelli, G, Margiotti, K, Sangiulo, F and Reichardt, JKV (2001) Pharmacogenetics of Human Androgens and Prostatic Diseases, Pharamacogenom. 2, 65-72

50. Okano, Y, Asadal, M, Fujimoto, A, Ohtake, A, Murayama, K, Hsiao, K-W, Choe, K, Reichardt, JKV, Niihira, S, Imamura, T and Yamano, T (2001) A Genetic Factor for Age-Related Cataract: Identification and Characterization of a Novel Galactokinase Variant "Osaka" in Asians, Am. J. Hum. Genet. 68, 1036-1042

51. Hsing, AW, Chen, C, Chokkalingam, AP, Gao, Y-T, Dightman, DA, Nguyen, HT, Deng, J, Cheng, J, Sesterhenn, IA, Mostofi, FK, Stanczyk, FW and Reichardt, JKV (2001) Polymorphic Markers in the SRD5A2 Gene and Prostate Cancer Risk: A Population-Based Case-Control Study, Cancer Epi. Biom. Prev. 10, 1077-1082

52. Ross RK, Reichardt JKV, Ingles SA, Coetzee GA (2001) The Genetic Epidemiology of Prostate Cancer: Closing in on a Complex Disease, in: Prostate Cancer: Biology, Genetics, and the New Therapeutics. (Eds) Chung LWK, Isaacs WB, Simons JW. Humana Press Inc., Totowa, NJ, 111-121

53. Makridakis, NM and Reichardt, JKV (2001) Molecular Epidemiology of Hormone-Metabolic Loci in Prostate Cancer, Epidemiol. Rev. 23, 24-29

54. Hsing, AW, Reichardt, JKV and Stanczyk, FW (2002) Hormones and Prostate Cancer: Current Perspectives and Future Directions, Prostate 52, 213- 235

55. Makridakis, NM and Reichardt, JKV (2001) MAPA: Multiplex Automated Primer Extension Analysis: Simultaneous Genotyping of up to Four Polymorphisms, Biotech. 31, 1374-1380

56. Pearce, CL, Makridakis, NM, Ross, RK, Pike, MC, Kolonel, LN, Henderson, BE and Reichardt, JKV (2002) SRD5A2 V89L Substitution is Not Associated with Significant Risk of Prostate Cancer in a Multi-Ethnic Population Study, Cancer Epi., Biom., Prev. 11, 417-418

57. Cozen W, Peters R, Reichardt JK, Ng W, Felix JC, Wan P, Pike MC (2002) Galactose-1-phosphate Uridyl Transferase (GALT) Genotype and Phenotype, Galactose Consumption, and the Risk of Borderline and Invasive Ovarian Cancer (United States), Cancer Causes Control. 13, 113-120

58. Goodman, MT, Wu, AH, Tung K-H, McDuffie K, Cramer DW, Wilkens LR, Terda K, Reichardt JKV and WG Ng (2002) Association of the Galactose-1- Phosphate Uridyltransferase (GALT) Activity and N314D Genotype with the Risk of Ovarian Cancer, Am. J. Epidem. 156, 693-701

59. Margiotti, K, Kim, E, Pearce, CL, Spera, E, Novelli, G and Reichardt, JKV (2002) Association of the G289S Polymorphism in the HSD17B3 Gene with Prostate Cancer in Italian Men, The Prostate 53, 65-68

60. Allen, NE, Reichardt, JKV, Nguyen, H, and Key, TJ (2003) Association between Two Polymorphisms in the SRD5A2 Gene and Serum Androgen Concentrations in British Men, Cancer Epidemiol. Biomarkers Prev. 12, 578- 581

61. Kobayashi, K, Lu YB, Li MX, Nishi I, Hsiao K-J, Choeh K, Yang Y, Hwu W- L, Reichardt, JKV, Palmieri F, Okano Y and Saheki T (2003) Screening for Nine SLC25A13 Mutations: Their Frequency in Patients with Citrin Deficiency and High Carrier Rates in Asian Populations, Molec. Genet. Metabol. 80, 356-359

62. Makridakis, NM and Reichardt, JKV (2004) Molecular Epidemiology of Androgen Metabolic Loci in Prostate Cancer and Progression, J. Urol. 171, S25-S29

63. Foti, D and Reichardt, JKV (2004) YY1 Binding within the Human HSD3B2 Gene Intron 1 is Required for Maximal Basal Promoter Activity: Identification of YY1 as the 31-A Factor, J. Molec. Endocrin. 33, 99-119

64. Novelli G, Margiotti K, Chiocca AM, Spera E, Micali F, Reichardt JK (2004) Pharmacogenetics of Human Androgens and Prostate Cancer--an Update, Pharmacogenom. 5, 283-294

65. Makridakis, NM, Akalu A, and Reichardt, JKV (2004) Identification and Characterization of Somatic Steroid 5-Reductase (SRD5A2) Mutations in Human Prostate Cancer Tissue, Oncogene 23, 7399-7405

66. Mehrian-Shai, R and Reichardt, JKV (2004) A Renaissance of “Biochemical Genetics”? SNPs, Haplotypes, Function and Complex Diseases, Molec. Genet. Metabol. 83, 47-50

67. Salam, MT, Ursin, G, Skinner, EC, Dessissa, T and Reichardt, JKV (2005) Associations between Polymorphisms in the Steroid 5- Reductase Type II (SRD5A2) Gene and Benign Prostatic Hyperplasia and Prostate Cancer, Urol. Oncol., 23, 246-253

68. Makridakis, N and JKV Reichardt (2005) Pharmacogenetic Analysis of Human Steroid 5 Reductase Type II: Comparison of Finasteride and Dutasteride, J. Molec. Endocrin. 34, 617-623

69. Mehrian Shai R, JKV Reichardt, Y-H Hsu, T Kremen, L Liau, T Cloughesy, P Mischel, SN Nelson (2005) Robustness of Gene Expression Profiling in Glioma Specimen Samplings and Derived Cell Lines, Molec. Brain Res. 136, 99-103

70. Makridakis, NM, Buchanan, G, Tilley, W and JKV Reichardt (2005) Androgen Metabolic Genes in Prostate Cancer Predisposition and Progression, Frontiers in Bioscience 10, 2899-2903

71. Mehrian-Shai, R and Reichardt, JKV (2006) Genomics in Breast and Prostate Cancer: Assessment of the Current State and Future Perspectives, Fut. Oncol. 2, 357-362

72. Reichardt, JKV (2006) Unexpected Biochemical and Pharmacogenetic Consequences of SNPs and Haplotypes: A Cautionary Tale for Human Molecular Genetics and Epidemiology, Genomics 88, 673-674

73. Chokkalingam AP, Stanczyk FZ, Reichardt JKV and Hsing AW (2007) Molecular Epidemiology of Prostate Cancer: Hormone-Related Genetic Loci, Frontiers in Bioscience 12, 3436-3460

74. Mehrian Shai R, Chen CD, Shi T, Horvath S, Nelson SF, Reichardt JKV and Sawyers CL (2007) IGFBP2 is a Biomarker for PTEN Status and PI3K/Akt Pathway Activation in Glioblastoma and Prostate Cancer, Proc. Natl. Acad. Sci. 104, 5563-5568

75. Reichardt JKV and Tilley WD (2007) The 3rd Pacific Rim Meeting on Breast and Prostate Cancer: Progress in Hormonal Carcinogenesis and the Enduring Influence of Ron Ross, Cancer Res. 67, 4550-4552

76. D’Amico F, Biancolella M, Reichardt JKV and Novelli G (2007) Single Nucleotide Polymorphisms in the Androgen Pathway and Prostate Cancer, Pharmacogenomics 8, 645-661

77. Reichardt JKV (2007) Quo vadis, genoma? A Call to Pipettes for Biochemists, Trends Biochem. Sci. 32, 529-530

78. Reichardt, JKV (2008) Realizing the Potential of the Sequenced Human Genome, Trends Genet. 24, 219-220

79. Pearce, CL, Van Den Berg, DJ, Makridakis, N, Reichardt, JKV, Ross, RK, Pike, MC, Kolonel, LN and Henderson, BE (2008) No Association Between the SRD5A2 Gene A49T Missense Variant and Prostate Cancer Risk: Lessons Learned, Hum. Molec. Genet. 17, 2456-2461

80. Mehrian Shai, R, Reichardt, JKV and Chen, T (2008) Pharmacogenomics of Brain Cancer and Personalized Medicine in Malignant Gliomas, Fut. Oncol., 4, 525-534

81. Chu, LW, Reichardt, JKV and Hsing, AW (2008) Androgens and the Molecular Epidemiology of Prostate Cancer, Curr. Opin. Endocrin. Diab. Obes. 15, 261-270

82. Makridakis, NM, Phipps, T and Reichardt, JKV (2009) Genomic Analysis of Cancer Tissue Reveals that Somatic Mutations Commonly Occur in a Specific Motif, Hum. Mut. 30, 39-48

83. Flanagan, JM, McMahon, G, Chia, SHB, Fitzpatrick, P, Tighe, O, O’Neill, C, Briones, P, Gort, L, Kozak, L, Naughten, AME, Radomyska, B, Schwartz, M, Shin, JS, Strobl, W, Tyfield, LA, Waterham, HR, Russell, H, Bertorelle, G, Reichardt, JKV, Mayne, PD, Croke, DT (2010) The Role of Human Demographic History in Determining the Distributionand Frequency of Transferase-Deficient Galactosaemia Mutations, Heredit. 104, 148-154

84. Makridakis, NM, Phipps, T, Srivastav, S and Reichardt, JKV (2009) PCR- Free Method Detects High Frequency of Genomic Instability in Prostate Cancer, Nucl. Acids Res. 37, 7441-7446

85. Musumeci, L, Arthur, JW, Cheung, FSG, Hoque, A, Lippman, S and Reichardt, JKV (2010) Single Nucleotide Differences (SNDs) in the dbSNP Database May Lead to Errors in Genotyping and Haplotyping Studies, Hum. Mut. 31, 67-73 (Commentary by Day, I (2010), Hum. Mut. 31, 2-4)

86. Das, K Lorena, DN, Ng, LK, Lim, D, Shen, L, Siow, WY, Teh, M, Reichardt, JKV, Salto-Tellez, M (2010) Differential Expression of Steroid 5-Reductase Isozymes and Association With Disease Severity and Angiogenic Genes Predict Their Biological Role in Prostate Cancer, Endocr. Relat. Cancer 17, 757-770

87. Goodman, P, Tangen, C, Kristal, A, Thompson, I, Lucia, S, Platz, E, Figg, W, Hoque, A, Hsing, A, Neuhouser, M, Parnes, H, Reichardt, J, Santella, R, Till, C and Lippman, S (2010) Transition of a Clinical Trial into Translational Research: The Prostate Cancer Prevention Trial Experience, Cancer Prev. Research 3, 1523-1533

88. Hulin-Curtis, SL, Petit, D, Figg, WD, Hsing, AW and Reichardt, JKV (2010) Finasteride Metabolism and Pharmacogenetics: New Approaches to Personalised Prevention of Prostate Cancer, Fut. Oncol. 6, 1897-1913

89. Price, DK, Chau, CH, Till, C, Goodman, PJ, Baum, CE, Ockers, SB, English, BC, Minasian, L, Parnes, HL, Hsing, AW, Reichardt, JKV, Hoque, A, Tangen, CM, Kristal, AR, Thompson, IM, Figg, WD (2010) Androgen Receptor CAG Repeat Length and Association with Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial, J. Urol. 184, 2297-2302

90. Arthur, JW and Reichardt, JKV (2010) Modelling Single Nucleotide Polymorphisms in The Human AKR1C1 and AKR1C2 Genes: Implications for Functional and Genotyping Analyses, PLoS ONE 5, 1-9

91. Tang, L, Song, Y, Till, C, Goodman, P, Tangen, C, Yu, W, Kristal, A, Platz, E, Neuhouser, M, Stanczyk, F, Reichardt, J, Santella, R, Hsing, A, Hoque, A, Lippman, S, Thompson, I, Ambrosone, C (2011) Repeat Polymorphisms in Estrogen Metabolism Genes and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial, Carcinogen. 32, 1500-1506

92. Yao, S, Till, C, Kristal, AR, Goodman, PJ, Hsing, AW, Tangen, CM, Platz, EA, Stanczyk, FZ, Reichardt, JKV, Tang, L, Neuhouser, ML, Santella, RM, Figg, WD, Price, DK, Parnes, HL, Lippman, SM, Thompson, IM, Ambrosone, CB and Hoque, A (2011) Serum Estrogen Levels and Prostate Cancer Risk in the Prostate Cancer Prevention Trial: a Nested Case-Control Study, Cancer Causes Control 22, 1121-1131

93. Cheung, FSG, Lovicu, FJ and Reichardt, JKV (2012) Current Progress In Using Vitamin D And Its Analogs For Cancer Prevention And Treatment, Expert Rev. Anticancer Ther., 12, 811-837

94. AR Kristal, C Till, CM Tangen, PJ Goodman, ML Neuhouser, FZ Stanczyk, LW Chu, SK Patel, I Thompson, JK Reichardt, A Hoque, EA Platz, WD Figg, A Van Bokhoven, SM Lippman, AW Hsing (2012) Associations of serum sex steroid hormones and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride, Cancer Epi. Biomark. Prev. 21, 1823-1832

95. Makridakis, NM and Reichardt, JKV (2012) Translesion DNA Polymerase and Cancer, Front. Pharmacogen. 3, article 174

96. Ho, G, Reichardt, J and Christodoulou, J (2013) In Vitro Read-through Of Phenylalanine Hydroxylase (PAH) Nonsense Mutations Using Aminoglycosides: A Potential Therapy For Phenylketonuria, J. Inh. Metabol. Dis. 36, 955-959

97. WD Figg, CH Chau, DK Price, C Till, PJ Goodman, Y Cho, M Varella- Garcia, JKV Reichardt, CM Tangen, RJ Leach, A van Bokhoven, IM Thompson, MS Lucia (2014) Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial, Urology, 84, 127-131

98. Toren A, Reichardt JK, Andalibi A, Hsu NY, Doherty J, Slattery W, Mehrian-Shai R (2014) Novel Age-Dependent Targets in Vestibular Schwannomas, Hum Genom. 8, doi: 10.1186/1479-7364-8-10

99. Yao, S, Till, CA, Kristal, AR, Goodman, PJ, Hsing, AW, Tangen, CM, Platz, EA, Stanczyk, FZ, Reichardt, J, van Bokhoven, A, Neuhouser, ML, Santella, RM, Figg, WD, Price, DK, Parnes, HL, Lippman, SL, Ambrosone, CB and Thompson, IM (2015) Effect of Finasteride on Serum Androstenedione and Risk of Prostate Cancer within the Prostate Cancer Prevention Trial: Differential Effect on High and Low Grade Disease, Urology, 85, 616-620

100. Arthur, JW, Cheung, FSG and Reichardt, JKV (2015) Single Nucleotide Differences (SNDs) Continue to Contaminate the dbSNP Database With Consequences For Human Genomics and Health Hum. Mut. 36, 196-199

101. CH Chau, DK Price, C Till, PJ Goodman, X Chen, RJ Leach, TL Johnson-Pais, AW Hsing A Hoque, CM Tangen, L Chu, HL Parnes, JM Schenk, JKV Reichardt, IM Thompson, WD Figg (2015) Finasteride Concentration and Prostate Cancer Risk: Results From The Prostate Cancer Prevention Trial, PLoS One, doi: 10.1371/journal.pone.0126672

102. R Mehrian-Shai, S Shams, J Doherty, W Slattery, S Freedman, NYH Hsu, JKV Reichardt, A Andalibi, A Toren (2015) Schwannomas exhibit distinct size dependent gene expression patterns, Fut. Oncol. 11, 1751-8

103. R Mehrian-Shai and JKV Reichardt (2015) Genomics is Changing Personal Healthcare and Medicine: The Dawn of iPH (Individualized Preventive Healthcare), Hum. Genomics, DOI 10.1186/s40246-015-0052-0

104. JM Schenk, C Till, AW Hsing, FZ Stanczyk, Z Gong, ML Neuhouser, JK Reichardt, AM Hoque, WD Figg, PJ Goodman, CM Tangen and IM Thompson (2016) Serum Androgens and Prostate Cancer Risk: Results From the Placebo Arm of the Prostate Cancer Prevention Trial, Cancer Causes Control, DOI 10.1007/s10552-015-0695-0

105. Mehrian-Shai, R, Yalon, M, Moshe, I, Barshack, I, Nass, D, Jacob, J, Dor, C, Reichardt, J, Constantini, S, and Toren, A (2016) Identification of Genomic Aberrations in Hemangioblastoma by Droplet Digital PCR and SNP Microarray Highlights Novel Candidate Genes and Pathways for Pathogenesis, BMC Genom. DOI: 10.1186/s12864-016-2370-6

106. DK Price, CH Chau, C Till, PJ Goodman, RJ Leach, TL Johnson-Pais, AW Hsing A Hoque, HL Parnes, JM Schenk, CM Tangen, IM Thompson, JKV Reichardt and WD Figg (2016) Association of Androgen Metabolism Gene Polymorphisms with Prostate Cancer Risk and Androgen Concentrations: Results from the Prostate Cancer Prevention Trial, Cancer, DOI: 10.1002/cncr.30071

107. A Toren, T Pismenyuk, M Yalon, S Freedman, A Simon, T Fisher, I Moshe, J Reichardt, S Constantini, Y Mardor, D Last, D Guez, D Daniels, M

Dagan, and R Mehrian-Shai (2016) Zinc Enhances Temozolomide Cytotoxicity in Glioblastoma Multiforme Model Systems, Oncotarget, DOI: 10.18632/oncotarget.11382.

Book Chapters

I Reichardt, J and B Ludwig (1981) Cytochrome c Interacts with Subunit II of the Cytochrome c Oxidase Isolated from Paraccccus denitrificans, in Vectorial Reactions in Electron Transport in Mitochondria and Bacteria (Palmieri, F. et al., eds.), 3-10

II Greenwood, C, AJ Thomson, CP Barrett, Peterson, GN George, JA Fee and J Reichardt (1988) Some Spectroscopic Views of the CuA Site in Cytochrome c Oxidase Preparations, Ann. NY Acad. Sci. 550, 47-52

III Reichardt, JKV (1993) Galactosemia is Caused by Missense Mutations: Molecular Studies and Implications for Therapy, in Galactosemia: New Frontiers for Research (Donnell, G.N., ed.), 199- 213

IV Reichardt, JKV (1993) Molecular Analysis of Galactosemia, in Current Progress in Perinatal Medicine (Cosmi, E.V. and G.C. Di Renzo, eds.), Parthenon, 225-229

V Daude, N and JKV Reichardt (1996) Molecular Genetic Basis of Epimerase-Deficiency Galactosemia, in Diagnosis and Treatment of Inborn Errors of Metabolism (Demirkol, M. and Y.S. Shin, eds.), Turkish Society for PKU, 49-55

VI Reichardt, JKV (1996) Molecular Genetic Basis of Galactosemia, in Diagnosis and Treatment of Inborn Errors of Metabolism (Demirkol, M. and Y.S. Shin, eds.), Turkish Society for PKU, 39-48

VII Petry, KG, N Daude, LLC Prestoz, E Ellie and JKV Reichardt (1996) Implication of Galactose-1-phosphate Uridyl Transferase (GALT) in the Process of Myelination and in the Ovarian Cycle, in Diagnosis and Treatment of Inborn Errors of Metabolism (Demirkol, M. and Y.S. Shin, eds.), Turkish Society for PKU, 153-164

VIII Ross RK, Reichardt JKV, Ingles SA, Coetzee GA (2001) The Genetic Epidemiology of Prostate Cancer: Closing in on a Complex Disease, in: Prostate Cancer: Biology, Genetics, and the New Therapeutics. (Eds) Chung LWK, Isaacs WB, Simons JW. Humana Press Inc., Totowa, NJ, 111-121

IX Akalu, A and Reichardt, JKV (2002) Increasing PCR Sensitivity for Amplification from Paraffin-Embedded Tissues, in PCR Cloning Protocols, 2nd Edition (Chen, B.-Y. and H.W. James, eds.), Methods Molec. Biol. 192, 67-74

X Ross RK, Makridakis NM, Reichardt JKV (2003) Prostate Cancer: Epidemiology and Molecular Endocrinology, in: Hormones, Genes,

and Cancer, (Henderson BE, Ponder B, Ross RK, eds.), Oxford University Press, Inc., New York, NY, 273-287

XI Makridakis, NM, Ross RK and Reichardt, JKV (2004) Human Genetic Variation at Hormone-Metabolic Loci and Prostate Cancer Risk, in Disorders of the Prostate (Habib, F, ed.) 63-69

XII Novelli, G, Margiotti, K, Spera, E, Micali, F and Reichardt, JKV (2005) Pharmacogenetics of Androgen-Metabolic Genes and Prostate Cancer, in Horizons in Cancer Research vol. 1 “Prostate Cancer” (Lucas, JN ed.), 81-101

XIII Reichardt, JKV and Hsing, AW (2009) Androgen Metabolic Genes in Prostate Cancer Predisposition and Progression, in Androgen Action in Prostate (Tindal, DJ and Mohler, JL, eds.), 141-154

XIV Mehrian-Shai, R, and Reichardt, JKV (2009) The Future of Human Genomics Research: Three Unanswered Questions, in Human Genome: Features, Variations and Genetic Disorders (Columbus, F., ed.), 295-300

XV Cheung, FSG and Reichardt, JKV (2010) Molecular Biology of Vitamin D Metabolism and Skin Cancer, in Vitamin D and Cancer (Johnson, C and Trump, D, eds.) Springer, 191-219

XVI Marques, FZC and Reichardt, JKV (2010) Pharmacogenetics of the Androgen Metabolic Pathway, in Drug Management of Prostate Cancer (Figg, WD et al., eds.), Springer, 109-121.

Theses

(1) Reichardt, J (1981) Crosslinking of Cytochrome c to the Cytochrome c Oxidase from Paracoccus denitrificans, Diploma Thesis, Universitaet Basel, Switzerland

(2) Reichardt, JKV (1989) Molecular Biology of Galactosemia, PhD Thesis, Stanford, CA.

Webpublications

A. Reichardt, JKV (2008) The Future of Human Genomics, The Science Advisory Board: http://www.scienceboard.net/community/perspectives.205.html

B. Reichardt, JKV and Mehrian-Shai, R (2008) Can Human Genomics Research Fulfill Its Promise? Science (E-Letter online), 3 july 2008 http://www.sciencemag.org/cgi/eletters/319/5871/1733#10837

C. Reichardt, JKV and Mehrian-Shai, R (2009) The Future of the Human SNP Identification: Which Individuals to Sequence? (Letter (Online Only)) Proc. Natl. Acad. Sci., 12 may 2009 http://www.pnas.org/content/106/19/E50.full?sid=b14eab01-bd71-4045-88f3- 3add6a556879